ALKS 8-K 2026-09-21

Alkermes plc. (ALKS) 8-K dated 2026-09-21 — accession 0001193125-26-396065. This URL is the filing, not the ALKS hub.

Alkermes plc. (ALKS) is a drug manufacturers - specialty & generic company listed on US.

Alkermes plc. filed a 8-K on 2026-09-21. Accession 0001193125-26-396065.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALKS revenue for 2025-12-31 was $1.48B. Net income was $241.7M. Revenue was down 5.2% from 2024-12-31 to 2025-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.

Not investment advice. The ALKS SEC hub lists recent forms. The stock page is the research view.